Catalyst Wire Dossier Catalyst Wire Dossier

HANDIHALER Dry Powder Inhaler

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HANDIHALER Dry Powder Inhaler, covering 2017-06-22 to 2017-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

See pricing